Akinsanya Karen insider trades
Akinsanya Karen has filed 17 Form 4s with the SEC that we hold, for Schrodinger, Inc. (SDGR) (See Remarks) and Nautilus Biotechnology, Inc. (NAUT) (Director). Across all of them we count 0 purchases worth $0 and 11 sales worth $3.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($972.0K). The largest single trade was a sale of 21,691 shares of Schrodinger, Inc. worth $1.2M, dated 2021-08-16. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-17 and the latest 2026-09-21.
Schrodinger, Inc. (SDGR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-16 | S, sale reported on Form 4 | 21,691 | $1.2M | 2021-08-17 | SEC |
| 2021-08-16 | S, sale reported on Form 4 | 16,047 | $933.5K | 2021-08-17 | SEC |
| 2021-09-15 | S, sale reported on Form 4 | 1,394 | $85.2K | 2021-09-16 | SEC |
| 2021-10-15 | S, sale reported on Form 4 | 1,393 | $77.7K | 2021-10-19 | SEC |
| 2025-04-14 | S, sale reported on Form 4 | 8,378 | $210.4K | 2025-04-15 | SEC |
| 2025-04-14 | S, sale reported on Form 4 | 5,000 | $125.5K | 2025-04-15 | SEC |
| 2025-04-14 | S, sale reported on Form 4 | 3,345 | $83.6K | 2025-04-15 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 2,206 | $26.4K | 2026-03-03 | SEC |
| 2026-03-05 | S, sale reported on Form 4 | 1,366 | $17.6K | 2026-03-06 | SEC |
| 2026-09-17 | S, sale reported on Form 4 | 10,000 | $280.0K | 2026-09-21 | SEC |
| 2026-09-17 | S, sale reported on Form 4 | 21,599 | $648.0K | 2026-09-21 | SEC |
Nautilus Biotechnology, Inc. (NAUT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1797672) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
